2-Acetamido-6-hydroxypurine

Catalog No. :
ACJUOL984
CAS No. :
19962-37-9
Molecular Formula :
C7H7N5O2
Molecular Weight :
193.17

IUPAC Name:N-(6-hydroxy-9H-purin-2-yl)acetamide

2-Acetamido-6-hydroxypurine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$61.00Login to see priceIn stockInquiry
100g98%$244.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Acetamido-6-hydroxypurine
IUPAC NameN-(6-hydroxy-9H-purin-2-yl)acetamide
MDL No.MFCD00078201
Molecular FormulaC7H7N5O2
Molecular Weight193.17
SMILESCC(=O)NC1=NC(O)=C2N=CNC2=N1
InChI KeyMXSMRDDXWJSGMC-UHFFFAOYSA-N
Synonymn-(6-hydroxy-9h-purin-2-yl)acetamide | N-(6-oxo-6,7-dihydro-3H-purin-2-yl)acetamide | N-Acetylguanine | AKOS015900671 | Q44 | MFCD00078201 | SCHEMBL10582271 | EN300-104477 | N-(6-Oxo-6,9-dihydro-1H-purin-2-yl)acetamide # | EINECS 243-443-7 | Acetamide, N-
CAS No.19962-37-9
PubChem CID135432176

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJUOL984 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. ACVCOZ324 route compound structure diagram
    ACVCOZ32473-40-5 In Stock
  4. Then
  5. ACJUOL984 route product structure diagram
    ACJUOL98419962-37-9 In Stock
Inquiry

2. ACJUOL984 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Plus
  5. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  6. Then
  7. ACJUOL984 route product structure diagram
    ACJUOL98419962-37-9 In Stock
Inquiry

Comments (0)